Joseph Murray, M.D., discusses a recent paper published from Isreal in the Health Economics Review that examines the economics of celiac disease. Not much is known about the economics and impact the diagnosis of celiac disease has on health care costs.
This study examines people diagnosed with celiac disease covered by one health insurance company and compares them to people that do not have celiac disease. The results show that people with celiac disease tend to have more health care costs and possibly more admissions to hospitals than the general public. The results also showed the costs of celiac disease are similar to patients that have diabetes or hypertension.
The major takeaways of this study are:
- There are costs associated with celiac disease that affect the health care system.
- Health care costs go down after the diagnosis of celiac disease.
It is important consider, look for, and treat celiac disease. By doing so, people will feel better and it will reduce the burden on the health care system.
The full text of the study can be found here.
For more information on celiac disease, visit mayoclinic.org/celiacdisease.
Dr. Murray is a gastroenterologist and celiac disease expert at Mayo Clinic.